Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

GKB OPHTHALMICS LTD.

NSE : NABSE : 533212ISIN CODE : INE265D01015Industry : Medical Equipment/Supplies/AccessoriesHouse : GKB

BSE74.02-1.98 (-2.61 %)

PREV CLOSE ( ) 76.00

OPEN PRICE ( ) 74.02

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 42

TODAY'S LOW / HIGH ( )74.02 74.02

52 WK LOW / HIGH ( ) 59131.75

NSE

This Company is not listed in NSE

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 10-12 1981

Management Info

KG Gupta - Chairman KG Gupta - Managing Director

Registered Office

Address 16- A,Tivim Industrial Estate, ,
Mapusa,
Goa-403526

Phone 0832 2257253 / 6714444

Email gkbophthalmics@gkb.net

Website www.gkb.net

Registrars Details

MUFG Intime India Pvt Ltd.

C 101, 247 Park,L B S Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE, Chennai, Kolkata

NEWS

02Jun GKB Ophthalmics informs about newspape
GKB Ophthalmics has informed that it attached copies of newspaper cuttin..

02Jun GKB Ophthalmics informs about press re
GKB Ophthalmics has informed that it attached copies of newspaper cuttin..

21Apr GKB Ophthalmics informs about change i
In reference to its earlier intimation dated January 09,2025 which infor..

29Mar GKB Ophthalmics informs about trading
GKB Ophthalmics has informed that the ‘Trading Window’ for dealing/tradi..

18Mar GKB Ophthalmics submits notice of inde
GKB Ophthalmics has informed that pursuant to Regulation 25 (3 and 4) of..

Financials

Rs. in Millions

	QTR Mar 25	ANNUAL 25
Net Profit	-24.8	-61.0899999999999
Gross Profit	-24.38	-60.3699999999999
Operating Profit	-11.77	-15.0699999999999
Net Sales	84.26	327.49

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

KMS Medisurgi (BSE) 126.50 (4.98%)	M.Cap ( in Cr)41.75
Centenial Surgical (BSE) 158.45 (1.57%)	M.Cap ( in Cr)57.81
Raaj Medisafe India (BSE) 100.00 (0.57%)	M.Cap ( in Cr)132.13
Laser Eyecare (BSE) 6.97 (1.90%)	M.Cap ( in Cr)4.88
Kretto Syscon (BSE) 2.00 (-0.50%)	M.Cap ( in Cr)125.44

Shareholding Pattern

	PROMOTERS	51.06%
	NON-INSTITUTION	47.16%
	MUTUAL FUNDS/UTI	0%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
No Data Found

Risk Disclosures on Derivatives

Smart Quotes

GKB OPHTHALMICS LTD.